The brain is a possible target for an angiotensinconverting enzyme inhibitor in the treatment of chronic heart failure
- 30 June 1998
- journal article
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 4 (2) , 139-144
- https://doi.org/10.1016/s1071-9164(98)90255-x
Abstract
No abstract availableKeywords
Funding Information
- Japan Science and Technology Agency (FY1997)
- Ministry of Education, Culture, Sports, Science and Technology (FY1997)
- Ministry of Health, Labour and Welfare (FY1997)
This publication has 23 references indexed in Scilit:
- The Effect of the Angiotensin-Converting–Enzyme Inhibitor Zofenopril on Mortality and Morbidity after Anterior Myocardial InfarctionNew England Journal of Medicine, 1995
- Increased angiotensin-I converting enzyme gene expression in the failing human heart. Quantification by competitive RNA polymerase chain reaction.Journal of Clinical Investigation, 1994
- Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.Circulation, 1994
- Contribution of Cardiac Renin-Angiotensin System to Ventricular Remodelling in Myocardial-Infarcted RatsJournal of Molecular and Cellular Cardiology, 1993
- Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure.Circulation Research, 1991
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986
- Afterload reduction: a comparison of captopril and nifedipine in dilated cardiomyopathy.Heart, 1986
- Vasodilator therapy for acute myocardial infarction and chronic congestive heart failureJournal of the American College of Cardiology, 1983